Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying those that can fulfill their potential is challenging due to associated risks and volatility [1] Group 1: Company Overview - Genpact is recommended as a cutting-edge growth stock based on its favorable Growth Score and top Zacks Rank [2] - The company has a historical EPS growth rate of 11.3%, with projected EPS growth of 9.2% this year, surpassing the industry average of 9% [4] Group 2: Financial Metrics - Genpact's asset utilization ratio is 0.95, indicating it generates $0.95 in sales for every dollar in assets, which is higher than the industry average of 0.9 [5] - The company's sales are expected to grow by 6.7% this year, compared to the industry average of 6.2% [6] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for Genpact, with the Zacks Consensus Estimate for the current year increasing by 2.7% over the past month [8] - Genpact has earned a Growth Score of B and carries a Zacks Rank 2 due to positive earnings estimate revisions, indicating it is a solid choice for growth investors [10]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence in investing [1] Zacks Style Scores - Zacks Style Scores provide a rating system for stocks based on value, growth, and momentum, serving as complementary indicators to the Zacks Rank [2] - Stocks are rated from A to F, with A indicating the highest potential for outperforming the market [3] Value Score - The Value Style Score identifies attractive and discounted stocks using ratios like P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - The Growth Style Score focuses on a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Style Score helps investors capitalize on price trends, utilizing factors like one-week price change and monthly earnings estimate changes [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive indicator for stocks with strong value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to assist in portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.86% since 1988 [7] - There are over 800 stocks rated, including more than 200 with a Strong Buy rank and 600 with a Buy rank, making stock selection potentially overwhelming [8] Investment Strategy - For optimal returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [9] - Stocks with a 3 (Hold) rank should also have Style Scores of A or B to maximize upside potential [9] Stock Highlight: Genpact - Genpact, based in Hamilton, Bermuda, is rated 2 (Buy) on the Zacks Rank and has a VGM Score of A [11] - The company has a Value Style Score of A, with a forward P/E ratio of 9.5, making it attractive for value investors [12] - Recent upward revisions in earnings estimates have increased the Zacks Consensus Estimate to $3.98 per share, with an average earnings surprise of +5.2% [12]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying stocks that can fulfill this potential is challenging [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Genpact (G) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly attractive [3] - Genpact has a historical EPS growth rate of 11.3%, with projected EPS growth of 9% this year, surpassing the industry average of 8.7% [4] Group 3: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for growth stocks, indicating efficiency in generating sales [5] - Genpact's S/TA ratio is 0.95, outperforming the industry average of 0.9, indicating higher efficiency [5] Group 4: Sales Growth - Sales growth is another key indicator, with Genpact expected to achieve a sales growth of 6.5% this year, compared to the industry average of 6.2% [6] Group 5: Earnings Estimate Revisions - Trends in earnings estimate revisions correlate strongly with near-term stock price movements, making them a valuable metric [7] - Genpact has seen upward revisions in current-year earnings estimates, with the Zacks Consensus Estimate increasing by 2.9% over the past month [8] Group 6: Overall Assessment - Genpact holds a Zacks Rank of 2 and a Growth Score of B, indicating it is a potential outperformer and a solid choice for growth investors [10]

Core Viewpoint - Genpact (G) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [4]. Business Outlook for Genpact - The upgrade reflects an improvement in Genpact's underlying business, suggesting that investors may respond positively by driving the stock price higher [5]. - For the fiscal year ending December 2025, Genpact is expected to earn $3.60 per share, with a 2.8% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance of Zacks Rank 1 stocks averaging a +25% annual return since 1988 [7]. - Genpact's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Core Insights - Zacks Premium provides tools for investors to enhance their stock market strategies and confidence, including daily updates on Zacks Rank and Industry Rank, Equity Research reports, and Premium stock screens [1][2] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum methodologies, helping investors identify stocks likely to outperform the market in the next 30 days [2][3] - Stocks are rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Style Score focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - The Growth Style Score evaluates stocks based on projected and historical earnings, sales, and cash flow to identify those with sustainable growth potential [4] Momentum Score - The Momentum Style Score assesses stocks based on price trends and earnings outlook changes, indicating optimal times to invest in high-momentum stocks [5] VGM Score - The VGM Score combines Value, Growth, and Momentum Scores, providing a comprehensive indicator for stock selection [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors, with 1 (Strong Buy) stocks achieving an average annual return of +23.81% since 1988, significantly outperforming the S&P 500 [7][8] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to refine their choices [8] Stock to Watch: Genpact - Genpact, based in Hamilton, Bermuda, specializes in managing business processes globally, leveraging process expertise and technology [11] - Genpact holds a Zacks Rank of 2 (Buy) and a VGM Score of A, indicating strong potential [11] - The company is projected to achieve year-over-year earnings growth of 7.9% for the current fiscal year, with upward revisions in earnings estimates from analysts [12] - The Zacks Consensus Estimate for Genpact's earnings has increased by $0.05 to $3.54 per share, with an average earnings surprise of +5.2% [12]

Core Viewpoint - Genpact is anticipated to report a year-over-year increase in earnings driven by higher revenues, with a consensus EPS estimate of $0.85, reflecting a 7.6% increase, and revenues expected to reach $1.23 billion, up 4.6% from the previous year [1][3]. Earnings Expectations - The upcoming earnings report is scheduled for August 7, and the stock may rise if the reported figures exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised 0.65% higher in the last 30 days, indicating a positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Genpact is higher than the consensus estimate, resulting in an Earnings ESP of +0.78%, suggesting a strong likelihood of beating the consensus EPS estimate [11]. - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [9]. Historical Performance - Genpact has consistently beaten consensus EPS estimates, achieving this in the last four quarters, with a notable surprise of +5.00% in the most recent quarter [12][13]. Industry Context - CDW, another player in the IT services industry, is expected to report an EPS of $2.49, reflecting a slight decline of 0.4% year-over-year, with revenues projected at $5.51 billion, up 1.6% [17]. - CDW's Earnings ESP stands at +2.41%, combined with a Zacks Rank of 2, indicating a strong likelihood of surpassing the consensus EPS estimate [18].